Subject: Real World Survey to understand the perception of healthcare professionals towards the use of Etoricoxib in the management of Acute & Chronic pain

Musculoskeletal pain is the main contributor to disability worldwide. According to the World Health Organization (WHO), 20–33% of the world’s population has some form of chronic musculoskeletal pain, translating to 1.75 billion people globally.

Musculoskeletal pain is defined as acute or chronic pain that affects bones, muscles, ligaments, tendons, and even nerves, and the pain associated with musculoskeletal disorders is a common medical and socioeconomic problem worldwide. It comprises a number of different pain syndromes, which range from local pain to neuropathic pain. Chronic musculoskeletal pain increases suffering in daily activities, drug consumption, and a high frequency of sick leave and disability pensions, and results in significantly diminished quality of life. It also poses a major public health problem, creating substantial costs for healthcare systems and disability insurance.

The most prevalent forms of musculoskeletal pain are chronic low back pain, neck pain, and the pain associated with osteoarthritis and rheumatoid arthritis, but musculoskeletal pain also includes sprained muscles, pain associated with fractures, shoulder pain, and others. Advancing age increases the risk of musculoskeletal pain, although it may occur at any age.

Selective COX-2 inhibitors have a greater affinity for COX-2 than COX-1. Etoricoxib a selective COX-2 inhibitor has demonstrated efficacy in many painful conditions. It has the largest selectivity among the Coxibs, a good absorption rate, and a half-life of 22 hours. Etoricoxib has a favorable tolerability profile and is associated with an improved quality of life.

This survey is designed to understand the perception of healthcare professionals towards the use of Etoricoxib in the management of Acute & Chronic pain.

If you agree to participate, you must respond to the survey questionnaire.

We hope you will consent to participate in this survey. If you do, please sign and return the enclosed reply along with your visiting card for the accuracy of records.